Solid state compatibility study and characterization of a novel degradation product of tacrolimus in formulation

Kino, 1987, FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics, J. Antibiot. (Tokyo), 40, 1249, 10.7164/antibiotics.40.1249 Kino, 1987, FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro, J. Antibiot. (Tokyo), 40, 1256, 10.7164/antibiotics.40.1256 Goto, 1987, Discovery of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis, Transplant. Proc., 19, 4 First, 2004, Tacrolimus based immunosuppression, J. Nephrol., 17, S25 Bowman, 2008, The role of tacrolimus in renal transplantation, Expert Opin. Pharmacother., 9, 635, 10.1517/14656566.9.4.635 Busuttil, 2004, Role of tacrolimus in the evolution of liver transplantation, Transplantation, 77, S44, 10.1097/01.TP.0000126927.49589.3F Yeoman, 2010, Review article: the modern management of autoimmune hepatitis, Aliment. Pharmacol. Ther., 31, 771 Lee, 2010, Tacrolimus for the treatment of active rheumatoid arthritis: a meta-analysis and systematic review, J. Rheumatol., 37, 1346 Lee, 2010, Tacrolimus for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials, Scand. J. Rheumatol., 39, 271, 10.3109/03009740903501642 Choe, 2013, Regulatory effect of calcineurin inhibitor, tacrolimus, on IL-6/sIL-6R-mediated RANKL expression through JAK2-STAT3-SOCS3 signaling pathway in fibroblast-like synoviocytes, Arthritis Res. Ther., 15, R26, 10.1186/ar4162 Dutta, 2011, The efficacy and safety of tacrolimus in rheumatoid arthritis, Ther. Adv. Musculoskelet. Dis., 3, 283, 10.1177/1759720X11419038 Simpson, 2005, Tacrolimus ointment – a review of its use in atopic dermatitis and its clinical potential in other inflammatory skin conditions, Drugs, 65, 827, 10.2165/00003495-200565060-00011 Nghiem, 2002, Tacrolimus and pimecrolimus. From clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis, J. Am. Acad. Dermatol., 46, 228, 10.1067/mjd.2002.120942 Nakagawa, 1994, Tacrolimus ointment for atopic-dermatitis, Lancet, 344, 883, 10.1016/S0140-6736(94)92855-X Akashi, 1996, Quantitative determination of tautomeric FK506 by reversed-phase liquid chromatography, J. Pharm. Biomed. Anal., 14, 339, 10.1016/0731-7085(95)01605-8 Namiki, 1993, Tautomeric phenomenon of a novel potent immunosuppressant (Fk506) in solution. 1. Isolation and structure determination of tautomeric compounds, J. Antibiot., 46, 1149, 10.7164/antibiotics.46.1149 Namiki, 1995, Determination of the immunosuppressive drug tacrolimus in its dosage forms by high-performance liquid-chromatography, Chromatographia, 40, 253, 10.1007/BF02290354 Ferraboschi, 2012, Evaluation, synthesis and characterization of tacrolimus impurities, J. Antibiot., 65, 349, 10.1038/ja.2012.28 ICH, 2006 ICH, 2006 Antipas, 2011, Solid-state excipient compatibility testing, 286 Bharate, 2010, Interactions and incompatibilities of pharmaceutical excipients with active pharmaceutical ingredients: a comprehensive review, J. Excip. Food Chem., 1, 3 Ok, 1990, Thermal rearrangement of the immunosuppressant Fk-506, Tetrahedron Lett., 31, 6477, 10.1016/S0040-4039(00)97095-3 Skytte, 2010, Synthesis and characterization of an epimer of tacrolimus, an immunosuppressive drug, J. Nat. Prod., 73, 776, 10.1021/np9007975 Subasranjan, 2010, An improved validated ultra high pressure liquid chromatography method for separation of tacrolimus impurities and its tautomers, Drug Test Anal., 2, 107 Ham, 2011, Identification of an 18-methyl derivative of tacrolimus API in Streptomyces clavuligerus CKD-1119, Bull. Korean Chem. Soc., 32, 109, 10.5012/bkcs.2011.32.1.109 Skytte, 2013, Some transformations of tacrolimus, an immunosuppressive drug, Eur. J. Pharm. Sci., 48, 514, 10.1016/j.ejps.2012.12.001 Shi, 2012, Development and validation of method for the determination of related substances of tacrolimus in tacrolimus capsules and degradation studies, Int. J. Chem. Tech. Res., 4, 1543 USP, 2014, 4813 Yamashita, 2003, Establishment of new preparation method for solid dispersion formulation of tacrolimus, Int. J. Pharm., 267, 79, 10.1016/j.ijpharm.2003.07.010 Honbo, 1987, The oral dosage form of Fk-506, Transplant. Proc., 19, 17 Baumann, 2004, On the reactivity of ascomycin at the binding domain. Part 2. Hydroxide mediated rearrangement reactions, Tetrahedron, 60, 5965, 10.1016/j.tet.2004.05.028 Smith, 2007 Askin, 1989, A mechanistic study of the Fk-506 tricarbonyl system rearrangement – synthesis of C.9 labeled Fk-506, Tetrahedron Lett., 30, 6121, 10.1016/S0040-4039(01)93320-9 Askin, 1989, Chemistry of Fk-506 – benzilic acid rearrangement of the tricarbonyl system, Tetrahedron Lett., 30, 671, 10.1016/S0040-4039(01)80278-1